Season 2 - Ep. 6: All you need to know about Lp(a) - Chronic total coronary occlusions

ESC TV Today – Your Cardiovascular News

Content provided by European Society of Cardiology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Society of Cardiology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

9M ago 20:53

MP3•Episode home

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

This episode covers:

Cardiology This Week: A concise summary of recent studies
All you need to know about Lp(a)
Chronic total coronary occlusions
Statistics Made Easy: The p-value

Host: Perry Elliott

Guests: Carlos Aguiar, Carlo di Mario, Lale Tokgozoglu

Want to watch that episode? Go to: https://esc365.escardio.org/event/1141

Disclaimer

This programme is intended for health care professionals only and is to be used for educational purposes.

The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

Declarations of interests

Stephan Achenbach, Carlo di Mario and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.

Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.

Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Lale Tokgozoglu has declared to have potential conflicts of interest to report: honoraria/consultancy from: Abbott, Amgen, AstraZeneca, Bayer, Daiichi Sankyo, Lilly, MSD, Novartis, Novo Nordisk, Sanofi, Pfizer, Ultragenyx.

47 episodes